OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CHEB55

Chembond Chemicals Ltd

Specialty ChemicalsVerified

Chembond Chemicals Ltd operates with a fully diluted share count of 26,896,576 shares, matching its basic share count, indicating no dilution from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, limiting the ability to assess its relative value or capital structure health. Profitability and return metrics are not available for Chembond, which prevents a direct comparison to industry_config preferred metrics or cohort medians. This lack of data also hinders the ability to evaluate its performance against peers in the Specialty Chemicals industry. Segment and geographic exposure details are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification. This opacity limits the ability to evaluate the company's exposure to regional economic shifts or supply chain disruptions. Growth trajectory is also unclear due to the absence of outlook data and revenue history. Without forward-looking guidance or historical performance, it is not possible to determine whether the company is expanding, contracting, or maintaining its current market position. Risk factors include the inability to assess liquidity risk, which could pose a challenge in periods of financial stress. The company is currently flagged for liquidity risk due to missing balance-sheet inputs and no going-concern language in source documents. Dilution risk is assessed as low, with no evidence of dilutive instruments or recent equity issuance. Recent events, including filings and transcripts, are not available in the current dataset, which limits the ability to evaluate management commentary, strategic shifts, or regulatory developments that may impact the company.

30-day price · CHEB+55.10 (+45.2%)
Low$104.85High$205.50Close$177.07As of12 May, 00:00 UTC
Profile
CompanyChembond Chemicals Ltd
TickerCHEB.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Chembond Chemicals Ltd is a specialty chemicals company that produces and markets a range of chemical products for industrial and consumer applications.

Classification. Chembond is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Chembond Chemicals Ltd operates with a fully diluted share count of 26,896,576 shares, matching its basic share count, indicating no dilution from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, limiting the ability to assess its relative value or capital structure health. Profitability and return metrics are not available for Chembond, which prevents a direct comparison to industry_config preferred metrics or cohort medians. This lack of data also hinders the ability to evaluate its performance against peers in the Specialty Chemicals industry. Segment and geographic exposure details are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification. This opacity limits the ability to evaluate the company's exposure to regional economic shifts or supply chain disruptions. Growth trajectory is also unclear due to the absence of outlook data and revenue history. Without forward-looking guidance or historical performance, it is not possible to determine whether the company is expanding, contracting, or maintaining its current market position. Risk factors include the inability to assess liquidity risk, which could pose a challenge in periods of financial stress. The company is currently flagged for liquidity risk due to missing balance-sheet inputs and no going-concern language in source documents. Dilution risk is assessed as low, with no evidence of dilutive instruments or recent equity issuance. Recent events, including filings and transcripts, are not available in the current dataset, which limits the ability to evaluate management commentary, strategic shifts, or regulatory developments that may impact the company.
Key takeaways
  • Chembond Chemicals Ltd has no dilution from stock options or convertible instruments, as basic and diluted share counts are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
  • Profitability and return metrics are not available, preventing a comparison to industry benchmarks.
  • Growth trajectory and revenue history are not disclosed, limiting visibility into the company's performance and future prospects.
  • Segment and geographic exposure details are not available, making it difficult to assess revenue concentration or diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2
FY-1$2.83B$397.4M$301.1M$128.2M
FY0$2.92B$376.6M$310.4M$312.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1$1.83B$1.44B
FY0$2.16B$1.74B
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1-$556.2M-$198.2M$128.2M
FY0$162.4M-$45.8M$312.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$643.6M$63.3M$55.9M
FQ-5$750.3M$73.9M$69.1M
FQ-4$748.8M$134.7M$99.7M
FQ-3$780.1M$98.2M$88.1M
FQ-2$653.8M$72.3M$62.6M
FQ-1$730.4M$93.6M$72.5M
FQ0$863.5M$110.4M$97.4M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1$2.18B$1.85B
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1$81.1M-$29.4M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricCHEBActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:01 UTC#a4176f71
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 15:29 UTCJob: 1bed005c